The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The partnership acknowledges the increasing mental health challenges faced by students in today's society
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
To enable company to be future-ready by tapping potential in CDMO space
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Subscribe To Our Newsletter & Stay Updated
